SK3298A3 - Use of ipriflavone to reduce the number of cd8+ cells - Google Patents

Use of ipriflavone to reduce the number of cd8+ cells Download PDF

Info

Publication number
SK3298A3
SK3298A3 SK32-98A SK3298A SK3298A3 SK 3298 A3 SK3298 A3 SK 3298A3 SK 3298 A SK3298 A SK 3298A SK 3298 A3 SK3298 A3 SK 3298A3
Authority
SK
Slovakia
Prior art keywords
cells
isopropoxyisoflavone
ipriflavone
cytotoxic
admixture
Prior art date
Application number
SK32-98A
Other languages
English (en)
Slovak (sk)
Inventor
B Attila Kovacs
Peter Aranyi
Terezia Kerepesi
Gyorgy Varai
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SK3298A3 publication Critical patent/SK3298A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SK32-98A 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells SK3298A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
SK3298A3 true SK3298A3 (en) 1998-07-08

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
SK32-98A SK3298A3 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Country Status (22)

Country Link
EP (1) EP0841915A1 (xx)
JP (1) JP2001503371A (xx)
KR (1) KR19990028933A (xx)
CN (1) CN1191483A (xx)
AR (1) AR002905A1 (xx)
AU (1) AU6367096A (xx)
BG (1) BG102182A (xx)
BR (1) BR9610187A (xx)
CA (1) CA2227421A1 (xx)
CZ (1) CZ2798A3 (xx)
EA (1) EA199800146A1 (xx)
EE (1) EE9800020A (xx)
HR (1) HRP960345A2 (xx)
HU (1) HU9502198D0 (xx)
IL (1) IL122751A0 (xx)
MX (1) MX9800603A (xx)
NO (1) NO980127D0 (xx)
PL (1) PL324460A1 (xx)
SK (1) SK3298A3 (xx)
WO (1) WO1997003664A1 (xx)
YU (1) YU42796A (xx)
ZA (1) ZA966079B (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
JP2001503371A (ja) 2001-03-13
CZ2798A3 (cs) 1998-06-17
WO1997003664A8 (en) 1999-08-05
ZA966079B (en) 1998-01-19
KR19990028933A (ko) 1999-04-15
YU42796A (sh) 1999-03-04
CN1191483A (zh) 1998-08-26
AR002905A1 (es) 1998-04-29
WO1997003664A1 (en) 1997-02-06
HRP960345A2 (en) 1998-02-28
BG102182A (en) 1998-08-31
PL324460A1 (en) 1998-05-25
IL122751A0 (en) 1998-08-16
HU9502198D0 (en) 1995-09-28
CA2227421A1 (en) 1997-02-06
EE9800020A (et) 1998-08-17
EP0841915A1 (en) 1998-05-20
NO980127L (no) 1998-01-12
EA199800146A1 (ru) 1998-08-27
BR9610187A (pt) 1998-07-28
MX9800603A (es) 1998-04-30
AU6367096A (en) 1997-02-18
NO980127D0 (no) 1998-01-12

Similar Documents

Publication Publication Date Title
JP3260378B2 (ja) 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用
BG64837B1 (bg) Приложение на диалкилфумарати
WO2007081974A2 (en) Viral hepatitis treatment
Sullivan et al. Lamotrigine‐induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management
WO1991002529A2 (en) Product and method for killing abnormal vertebrate cells
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
JPH0489428A (ja) 多形核白血球活性化剤
EP0972519B1 (en) Immune tolerance inducers
EP0544802B1 (en) Methods and compositions for treating t-cell mediated diseases
SK3298A3 (en) Use of ipriflavone to reduce the number of cd8+ cells
EP0081882A1 (en) Medicine having transplant rejection and/or immunological inflammation inhibiting activities, as well as a method for inhibiting transplant rejection and/or immunological inflammation
Hinterberger-Fischer et al. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders: report of 5 cases
CN107737108B (zh) 一种治疗心肌梗死后心室重塑的口服药物组合物
WO1997005896B1 (en) Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
JPH06135836A (ja) コントラサプレッサー細胞の誘導剤
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
EP2994133A1 (en) Compositions and method for treatment of ischemic neuronal reperfusion injury
GB2189703A (en) Vinpocetine
MXPA98000603A (en) Use of ipriflavona to reduce the number of cells c
Chang et al. Activity of roxithromycin against Toxoplasma gondii in murine models
EP0005074A1 (en) A material and composition for reducing blood pressure
EP0347927A2 (de) Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on (Ebselen) zur Herstellung von Arzneimitteln zur Behandlung von Malaria
EP0256629A2 (en) Tolrestat or a salt thereof as an immuno-stimulating agent
DE2215728A1 (de) Arzneimittel zur behandlung von herpes simplex
JP2545279B2 (ja) 血小板減少予防及び治療剤